Patrick is a vaccines markets consultant who can advise clients on all aspects of US vaccines launches and commercialization. Most recently at GlaxoSmithKline (GSK), Patrick led the US market access launch for SHINGRIX, GSK's shingles vaccines. Prior to GSK he spent ten years with Merck in market access, public policy and vaccines public policy roles, leading work that established Medicare Part D's vaccine benefit. In addition, Patrick spent six years with CMS, serving as a federal compliance inspector for Medicaid waiver programs and supporting implementation of the Medicare Part D drug benefit.